The global burden of diabetes is rapidly increasing, and expected to top 693 million by 2045. The subtle onset of type 2 diabetes delays diagnosis and increases morbidity.
Given the multifactorial vascular effects of diabetes, RE.DOCTOR has developed a smartphone-based photoplethysmography (PPG) tool that provides a widely-accessible digital biomarker for diabetes.
Research and testing partners are needed to fully exploit the technology. Learn more at https://re.doctor/en/research-partners/